<i>IDH1/2</i> Mutation and <i>MGMT</i> Promoter Methylation – the Relevant Survival Predictors in Czech Patients with Brain Gliomas Cited by

Fol. Biol. 2016, 62, 194-202

https://doi.org/10.14712/fb2016062050194

IDH1/2 Mutation and MGMT Promoter Methylation – the Relevant Survival Predictors in Czech Patients with Brain Gliomas

Filip Kramář¹, M. Minárik², L. Benešová², T. Halková², D. Netuka¹, O. Bradáč¹, V. Beneš¹

¹Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital Prague, Czech Republic
²Center for Applied Genomics of Solid Tumors (CEGES), Genomac Research Institute, Ltd, Prague, Czech Republic

Received January 2016
Accepted June 2016

Crossref Cited-by Linking

Oh Ji Hoon, Cho Je-Yoel: Comparative oncology: overcoming human cancer through companion animal studies. Exp Mol Med 2023, 55, 725. <https://doi.org/10.1038/s12276-023-00977-3>
IUS Tamara, PIGNOTTI Fabrizio, DELLA PEPA Giuseppe M., BAGATTO Daniele, ISOLA Miriam, BATTISTELLA Claudio, GAUDINO Simona, PEGOLO Enrico, CHIESA Silvia, ARCICASA Mauro, LA ROCCA Giuseppe, OLIVI Alessandro, SKRAP Miran, SABATINO Giovanni: Glioblastoma: from volumetric analysis to molecular predictors. J Neurosurg Sci 2022, 66. <https://doi.org/10.23736/S0390-5616.20.04850-X>
Jovanovi\u0107 Nikola, Lazarevi\u0107 Milica, Cvetkovi\u0107 Vladimir J., Nikolov Vesna, Kosti\u0107 Peri\u0107 Jelena, Ugrin Milena, Pavlovi\u0107 Sonja, Mitrovi\u0107 Tatjana: The Significance of MGMT Promoter Methylation Status in Diffuse Glioma. IJMS 2022, 23, 13034. <https://doi.org/10.3390/ijms232113034>
Ang Samantha Ya Lyn, Lee Lester, See Angela An Qi, Ang Ting Yao, Ang Beng Ti, King Nicolas Kon Kam: Incidence of biomarkers in high-grade gliomas and their impact on survival in a diverse SouthEast Asian cohort - a population-based study. BMC Cancer 2020, 20. <https://doi.org/10.1186/s12885-020-6536-x>
Shen Guiquan, Wang Rujia, Gao Bo, Zhang Zhongwen, Wu Guipeng, Pope Whitney: The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China. Front. Oncol. 2020, 10. <https://doi.org/10.3389/fonc.2020.00852>
Stoyanov George S., Dzhenkov Deyan, Ghenev Peter, Iliev Bogomil, Enchev Yavor, Tonchev Anton B.: Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment. Med Oncol 2018, 35. <https://doi.org/10.1007/s12032-018-1083-x>
Jin Shuai, Qian Zenghui, Liang Tingyu, Liang Jingshan, Yang Fuqiang, Sun Lihua, Li Wenbin, Qiu Xiaoguang, Zhang Man: Identification of a DNA Repair-Related Multigene Signature as a Novel Prognostic Predictor of Glioblastoma. World Neurosurgery 2018, 117, e34. <https://doi.org/10.1016/j.wneu.2018.05.122>
Gong Mingjie, Shi Wei, Qi Jing, Shao Guoping, Shi Zhenghua, Wang Junxiang, Chen Jian, Chu Rongtao: Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma. Oncotarget 2017, 8, 76797. <https://doi.org/10.18632/oncotarget.20012>